Glybera (alipogene tiparvovec) - uniQure, Chiesi, Xenon
Gendicine (rAd-p53 Gene Therapy) - Benda Pharma
Imlygic (talimogene laherparepvec) - Amgen
Strimvelis (autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence) - Orchard Therap
http://www.globenewswire.com/news-release/2019/04/26/1810468/0/en/Global-Viral-Vector-Manufacturing-Market-to-2024-Market-is-Expected-to-Register-a-CAGR-of-19-Key-Players-are-Sanofi-Merck-Fujifilm-Diosynth-Biotechnologies-Thermofisher-Scientific-.html
 
Apr 26, 2019
 
Prev Next